A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

Condition:   Relapsing Multiple Sclerosis
Interventions:   Drug: Interferon beta-1a;   Drug: Ocrelizumab-matching placebo;   Drug: Ocrelizumab;   Drug: Interferon beta-1a-matching placebo
Sponsor:   Hoffmann-La Roche
Active, not recruiting